FCG Advisors’s Celgene Corporation Contingent Value Rights CELGZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-52,807
| Closed | -$30K | – | 172 |
|
|
2019
Q3 | $30K | Sell |
52,807
-56,410
| -52% | -$31.4K | 0.01% | 160 |
|
|
2019
Q2 | $68K | Hold |
109,217
| – | – | 0.02% | 157 |
|
|
2019
Q1 | $121K | Sell |
109,217
-52,261
| -32% | -$51.1K | 0.04% | 147 |
|
|
2018
Q4 | $73K | Sell |
161,478
-39,454
| -20% | -$36K | 0.03% | 135 |
|
|
2018
Q3 | $321K | Hold |
200,932
| – | – | 0.11% | 100 |
|
|
2018
Q2 | $72K | Sell |
200,932
-1,126
| -0.6% | -$339 | 0.03% | 135 |
|
|
2018
Q1 | $59K | Sell |
202,058
-158
| -0.1% | -$104 | 0.02% | 122 |
|
|
2017
Q4 | $196K | Sell |
202,216
-269
| -0.1% | -$309 | 0.07% | 116 |
|
|
2017
Q3 | $307K | Sell |
202,485
-559
| -0.3% | -$683 | 0.11% | 93 |
|
|
2017
Q2 | $252K | Sell |
203,044
-5,532
| -3% | -$6.34K | 0.08% | 119 |
|
|
2017
Q1 | $225K | Sell |
208,576
-923
| -0.4% | -$1.01K | 0.09% | 108 |
|
|
2016
Q4 | $216K | Sell |
209,499
-90,811
| -30% | -$102K | 0.1% | 99 |
|
|
2016
Q3 | $312K | Buy |
300,310
+367
| +0.1% | +$443 | 0.1% | 90 |
|
|
2016
Q2 | $438K | Sell |
299,943
-4,372
| -1% | -$5.63K | 0.14% | 79 |
|
|
2016
Q1 | $353K | Sell |
304,315
-3,199
| -1% | -$4.28K | 0.12% | 71 |
|
|
2015
Q4 | $369K | Sell |
307,514
-1,142
| -0.4% | -$1.52K | 0.22% | 60 |
|
|
2015
Q3 | $497K | Buy |
308,656
+4,358
| +1% | +$8.41K | 0.41% | 49 |
|
|
2015
Q2 | $633K | Sell |
304,298
-11,308
| -4% | -$28.9K | 0.5% | 43 |
|
|
2015
Q1 | $937K | Sell |
315,606
-3,424
| -1% | -$10.8K | 0.48% | 38 |
|
|
2014
Q4 | $1.07M | Buy |
+319,030
| New | +$1.08M | 0.53% | 42 |
|
|
2014
Q3 | – | Sell |
-323,456
| Closed | -$841K | – | 96 |
|
|
2014
Q2 | $841K | Sell |
323,456
-163,869
| -34% | -$453K | 0.64% | 36 |
|
|
2014
Q1 | $1.37M | Buy |
487,325
+37,571
| +8% | +$114K | 0.97% | 29 |
|
|
2013
Q4 | $1.23M | Buy |
449,754
+419,438
| +1,384% | +$1.18M | 0.83% | 29 |
|
|
2013
Q3 | $243K | Buy |
+30,316
| New | +$234K | 0.17% | 63 |
|
FCG Advisors's CELGZ Position: Q4 2019 in Review
FCG Advisors sold out of Celgene Corporation Contingent Value Rights (CELGZ) in Q4 2019, closing a stake of 52,807 shares — an estimated $30K sold.
FCG Advisors first reported a position in CELGZ in Q3 2013 and held it in 24 quarters. The position peaked at $1.37M in Q1 2014. 0 funds tracked by Wall St. Rank hold CELGZ as of Q4 2019.
- FCG Advisors reported no remaining Celgene Corporation Contingent Value Rights position as of Q4 2019 after selling out during the quarter.
- FCG Advisors sold 52,807 Celgene Corporation Contingent Value Rights shares in Q4 2019, an estimated $30K.
- FCG Advisors first reported a position in Celgene Corporation Contingent Value Rights in Q3 2013 and held it in 24 quarters.
- FCG Advisors's Celgene Corporation Contingent Value Rights position peaked at $1.37M in Q1 2014.
- 0 funds tracked by Wall St. Rank held Celgene Corporation Contingent Value Rights as of Q4 2019.
Based on FCG Advisors's 13F filing for Q4 2019, filed 29 Jan 2020.